For tough 2010, pharma cuts billions from R&D
Over the last week or so, we’ve seen three Big Pharmas announce big changes to their research operations–and those big changes include big job cuts. Big cost savings, too, the companies say. The new cuts are hitting the news along with pharma earnings, which, so far, have been more than respectable. It’s 2010 that everyone’s worried about. Analysts haven’t been cheering
